Erlonat 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
Erlonat 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.
BENEFITS OF ERLONAT TABLET
In Non-small cell lung cancer
SIDE EFFECTS OF ERLONAT TABLET
Common side effects of Erlonat
- Abdominal pain
- Bone pain
- Muscle pain
- Stomatitis (Inflammation of the mouth)
- Weight loss
HOW TO USE ERLONAT TABLET
HOW ERLONAT TABLET WORKS
Use of this medicine is not advised in patients with severe kidney disease.
Limited information is available on the use of Erlonat 150 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate liver disease.